IP
AGNT

Isomer Partners’s AGNT Inc AGNT Stock Holding History

Isomer Partners’s Portfolio AGNT Stock Details AGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150,000
Closed -$4.73M – 24
2020
Q4 		$4.73M Buy
+150,000
New +$4.14M 0.77% 18

Other funds holding AGNT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Isomer Partners's AGNT Position: Q4 2024 in Review

Isomer Partners sold out of AGNT Inc (AGNT) in Q4 2024, closing a stake of 150,000 shares — an estimated $2.11M sold.

Isomer Partners first reported a position in AGNT in Q2 2024 and held it in 2 quarters. The position peaked at $2.11M in Q3 2024. 238 funds tracked by Wall St. Rank hold AGNT as of Q4 2024.

  • Isomer Partners reported no remaining AGNT Inc position as of Q4 2024 after selling out during the quarter.
  • Isomer Partners sold 150,000 AGNT Inc shares in Q4 2024, an estimated $2.11M.
  • Isomer Partners first reported a position in AGNT Inc in Q2 2024 and held it in 2 quarters.
  • Isomer Partners's AGNT Inc position peaked at $2.11M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held AGNT Inc as of Q4 2024.

Based on Isomer Partners's 13F filing for Q4 2024, filed 3 Feb 2025.